COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 1720: Articles 17191-17200  | Next

Histopathological assessments reveal retinal vascular changes, inflammation, and gliosis in patients with lethal COVID-19
JIDIGAM, V. K., SINGH, R., BATOKI, J. C., MILLINER, C., SAWANT, O. B., BONILHA, V. L., RAO, S.
10.1101/2021.02.25.21251531 — Posted: 2021-02-28 Discussion: Offsite
GUIdeStaR (G-quadruplex, Uorf, IRES, Small RNA, Repeats), bioinformatics tool for gene characterization- case study: development of attribute selection and classification methods based on GuideStar for studying human transcription factor genes mediated by SARS-COV-2 small ncRNA
Kang, J. E.
10.1101/2021.02.25.432957 — Posted: 2021-02-27
A statewide analysis of SARS-CoV-2 transmission in New York
Lasek-Nesselquist, E., Singh, N., Russell, A., Lamson, D., Kelly, J., Plitnick, J., Pfeiffer, R. D., Tucker, N., Schneider, E., St. George, K.
10.1101/2021.02.20.21251598 — Posted: 2021-02-27
Comparative infectivity and pathogenesis of emerging SARS-CoV-2 variants in Syrian hamsters
Abdelnabi, R., Boudewijns, R., Foo, C. S.-Y., Seldeslachts, L., Sanchez-Felipe, L., Zhang, X., Delang, L., Maes, P., Kaptein, S. J. F., Weynand, B., Vande Velde, G., Neyts, J., Dallmeier, K.
10.1101/2021.02.26.433062 — Posted: 2021-02-26
Graphene oxide/silver nanoparticle ink formulations rapidly inhibit influenza A virus and OC43 coronavirus infection in vitro
Crane, M. J., Devine, S., Jamieson, A. M.
10.1101/2021.02.25.432893 — Posted: 2021-02-26
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants
Wang, L., Zhou, T., Zhang, Y., Yang, E. S., Schramm, C. A., Shi, W., Pegu, A., Oloninyi, O. K., Ransier, A., Darko, S., Narpala, S. R., Hatcher, C., Martinez, D. R., Tsybovsky, Y., Phung, E., Abiona, O. M., Cale, E. M., Change, L. A., Corbett, K. S., DiPiazza, A. T., Gordon, I. J., Leung, K., Liu, T., Mason, R. D., Nazzari, A., Novik, L., Olia, A. S., Stephens, T., Stringham, C. D., Talana, C. A., Teng, I.-T., Wagner, D., Widge, A. T., Zhang, B., Roederer, M., Ledgerwood, J. E., Ruckwardt, T. J., Gaudinski, M. R., Baric, R. S., Graham, B. S., McDermott, A. B., Doueck, D. C., Kwong, P. D., Mascola, J. R., Sullivan, N. J., Misasi, J.
10.1101/2021.02.25.432969 — Posted: 2021-02-26
Prophylaxis for covid-19: living systematic review and network meta-analysis
Bartoszko, J. J., Siemieniuk, R. A., Kum, E., Qasim, A., Zeraatkar, D., Ge, L., Han, M. A., Sadeghirad, B., Agarwal, A., Agoritsas, T., Chu, D. K., Couban, R., Darzi, A. J., Devji, T., Ghadimi, M., Honarmand, K., Izcovich, A., Khamis, A., Lamontagne, F., Loeb, M., Marcucci, M., McLeod, S. L., Motaghi, S., Murthy, S., Mustafa, R. A., Neary, J. D., Pardo-Hernandez, H., Rada, G., Rochwerg, B., Switzer, C., Tendal, B., Thabane, L., Vandvik, P. O., Vernooij, R. W., Viteri-Garcia, A., Wang, Y., Yao, L., Ye, Z., Guyatt, G. H., Brignardello-Petersen, R.
10.1101/2021.02.24.21250469 — Posted: 2021-02-26 Discussion: Onsite
Discovery of SARS-CoV-2 strain of P.1 lineage harboring K417T/ E484K / N501Y by whole genome sequencing in the city, Japan
Hirotsu, Y., Omata, M.
10.1101/2021.02.24.21251892 — Posted: 2021-02-26
SARS-CoV-2 Viremia is Associated with Distinct Proteomic Pathways and Predicts COVID-19 Outcomes
Li, Y., Schneider, A. M., Mehta, A., Sade-Feldman, M., Kays, K. R., Gentili, M., Charland, N. C., Gonye, A. L., Gushterova, I., Khanna, H. K., LaSalle, T. J., Lavin-Parsons, K. M., Lilley, B. M., Lodenstein, C. L., Manakongtreecheep, K., Margolin, J. D., McKaig, B. N., Parry, B. A., Rojas-Lopez, M., Russo, B. C., Sharma, N., Tantivit, J., Thomas, M. F., Regan, J., Flynn, J. P., Villani, A.-C., Hacohen, N., Goldberg, M. B., Filbin, M. R., Li, J. Z.
10.1101/2021.02.24.21252357 — Posted: 2021-02-26
Sex differences in the mortality rate for coronavirus disease 2019 compared to other causes of death
Geldsetzer, P., Mukama, T., Jawad, N. K., Riffe, T., Rogers, A., Sudharsanan, N.
10.1101/2021.02.23.21252314 — Posted: 2021-02-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).